Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
LYFE Capital is a healthcare investment platform founded in 2015 by a group of investment veterans and operators. The firm operates from five global offices located in Menlo Park, California; Seoul, South Korea; Shanghai, China; Tokyo, Japan; and Singapore. LYFE Capital focuses on investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services. The firm aims to facilitate significant revenue growth by concentrating on mature global markets and leveraging the unique advantages of both Asian cost efficiencies and U.S. innovation.
As of now, LYFE Capital manages approximately $2 billion in assets under management (AUM) and has completed 108 investments across various healthcare sectors. The firm has established a strong reputation for its strategic approach to building substantial positions in high-growth potential leaders within the healthcare ecosystem. Notable milestones include a successful track record of IPOs, with eight companies listed on NASDAQ, including Cytek Biosciences and Burning Rock.
LYFE Capital invests in healthcare companies that are essential to the global value chain, with a specific focus on sectors such as healthcare, biotech, pharma-tech, and health-data. The firm targets investments at various stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C. LYFE Capital emphasizes building meaningful positions in high-growth potential leaders, employing a strategy that includes geographic revenue expansion and bolt-on acquisitions. This approach allows the firm to capitalize on the strengths of both Asian markets and U.S. innovation.
In their own words, LYFE Capital seeks to invest in critical healthcare supply chain assets and next-generation R&D services. The firm looks for companies that demonstrate strong growth potential and the ability to navigate complex regulatory environments. Their investment strategy is designed to leverage cross-border opportunities between Asia and the U.S., driving growth in the healthcare sector while enhancing operational efficiencies and market reach.
LYFE Capital manages a strategic portfolio of leading healthcare companies, including:
Notable exits from LYFE Capital's portfolio include Cytek Biosciences, Burning Rock, Kyverna Therapeutics, and Pliant Therapeutics, showcasing the firm's ability to identify and support high-potential healthcare companies.
Frances Chovanec: Managing Director with extensive experience in healthcare investments and operational management.
Jack Chen: Partner specializing in cross-border investments and market expansion strategies.
William Chen: Partner with a focus on healthcare technology and innovation.
Yao Li Ho: Managing Director known for her expertise in Asian markets and healthcare supply chains.
Alvin Koh: Investment Principal and Senior Director of APAC Business Development, bringing a wealth of knowledge in business development and strategic partnerships.
To pitch LYFE Capital, founders should send their proposals via email to newlp@lyfecapital.com. It is essential to include a comprehensive deck that outlines the business model, market analysis, and financial projections. LYFE Capital appreciates well-structured pitches that clearly convey the startup's value proposition and growth strategy. Response times may vary, but founders can expect to hear back within a few weeks.
In January 2026, LYFE Capital achieved a notable exit with Edge Medical, further solidifying its reputation in the healthcare investment space. The firm has completed a total of 108 investments, with 15 successful exits to date. LYFE Capital's Fund IV is currently active, continuing its strategy of investing in high-potential healthcare companies.
Recent activity also includes eight IPOs on NASDAQ, featuring companies such as Cytek Biosciences and Burning Rock, showcasing the firm's strong track record in identifying and supporting successful healthcare ventures.
What are LYFE Capital's investment criteria?
LYFE Capital focuses on healthcare companies that are pivotal to the global healthcare ecosystem, emphasizing high-growth potential and the ability to navigate complex regulatory environments.
How can founders apply or pitch to LYFE Capital?
Founders can pitch to LYFE Capital by sending an email to newlp@lyfecapital.com. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes LYFE Capital different from other investors?
LYFE Capital differentiates itself through its focus on cross-border opportunities between Asia and the U.S., leveraging unique market advantages to drive growth in healthcare investments.
What is LYFE Capital's geographic scope?
LYFE Capital invests globally, with a strong emphasis on North America and Asia, allowing them to tap into diverse healthcare markets and innovations.
What is LYFE Capital's post-investment involvement like?
LYFE Capital provides strategic guidance in geographic expansion, operational efficiencies, and leveraging cross-border synergies, actively supporting portfolio companies in their growth journeys.
What is the typical fund size and check size for LYFE Capital?
LYFE Capital has a total fund size of $2 billion, with investments made across various stages, including pre-seed to Series C, although specific check sizes are not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.